Articles by Robert Langreth and Jef Feeley

U.S. Study Questions Baby Powder Link to Ovarian Cancer

A study of more than 250,000 women found that those who used talc or other personal-hygiene powders weren’t significantly more likely to develop ovarian cancer, news that will impact thousands of legal claims against drugmaker Johnson & Johnson over the …

Vaping Lung Injury Cases Down; Link to Vitamin E Acetate Reinforced

Most patients stricken in a wave of vaping-related injuries had vitamin E acetate in their lungs, U.S. health officials found, reinforcing a suspected link between the compound and an outbreak that spurred a national debate about the safety of the …

Vaping Safety Debate Between Researchers, Activists Intensifies with Mystery Illness

Portland State University chemistry professor David Peyton had never been attacked with such intensity. Peyton and a group of other chemists discovered almost five years ago that e-cigarettes could sometimes produce more cancer-causing formaldehyde than regular cigarettes. Formaldehyde is produced …

Study Points to Toxic Chemicals as Likely Cause of Vaping Lung Ailments

Vaping-related lung injuries are most likely caused by exposure to toxic chemicals rather than fatty substances like mineral oils, according to a new analysis of patient tissue by Mayo Clinic pathologists. The results, based on lung biopsies from 17 patients …

How Early Signs of Lung Effects of Vaping Were Missed and Downplayed

Scientists, regulators and e-cigarette proponents missed, ignored or downplayed signs that vaping could significantly damage the lungs for nearly a decade, a review of medical literature, government documents and interviews with doctors shows. At least 15 incidents of lung injuries …

How Pharmacies Are Resisting Amazon’s Attempt to Corner Their Business

Getting into the pharmacy business was easy for Amazon.com: It paid $753 million to buy the mail-order startup PillPack. The hard part has been prying patients away from their local drugstore. Since being acquired by the internet giant, PillPack has …

States, Congress Questioning Pharmacy Benefit Managers’ Role in Drug Prices

Several states are probing pharmacy-benefit managers’ business practices in government-sponsored health programs, adding to the scrutiny the middlemen face in Washington for their role in the cost of drugs. At least three state attorneys general are investigating PBMs, in addition …

Senators Seek Probe of Pharmacy Benefit Managers’ Pricing Practice

Two U.S. senators have asked the inspector general of the Health and Human Services Department to investigate a practice by pharmacy-benefit managers known as spread pricing, as part of a wider inquiry by lawmakers into U.S. drug costs. Ron Wyden …

Trump Plan to Curb Drug Prices Targets Rebates to Pharmacy Benefit Managers

The Trump administration proposed ending a complex system of drug rebates that influence tens of billions of dollars in U.S. pharmaceutical spending, a move that could upend the relationship between drugmakers and pharmacy benefits middlemen. The proposal, a long-awaited part …

Investor Icahn to Oppose Cigna-Express Deal, Fearing Amazon Threat: Sources

Activist investor Carl Icahn has built a sizable stake in Cigna Corp. and plans to oppose the health insurer’s $54 billion takeover of pharmacy-benefits firm Express Scripts Holding Co., according to people familiar with the matter. Chief among Icahn’s concerns …